Cleveland BioLabs (CBLI) volatility at historic lows

Cleveland BioLabs (Nasdaq: CBLI), a company developing a treatment for Acute Radiation Syndrome which can also be utilized as a radioprotectant in radiation oncology, is recently trading at $7.52. Overall option implied volatility of 58 is below its six-month average of 77 according to Track Data, suggesting decreasing price movement.

---

Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!